• Phosphatidic Acid Drives Decidualization via Src-FAK-RhoA-RO

  2026-04-29

  This study identifies the Src-FAK-RhoA/ROCK signaling cascade as a pivotal regulator of cytoskeletal remodeling during phosphatidic acid-induced decidualization in human endometrial stromal cells. The findings clarify an independent molecular route for morphological transformation, with implications for infertility research and targeted pathway modulation.

• QRICH1 Drives HBV-Induced HMGB1 Secretion via ER Stress in H

  2026-04-28

  The referenced study uncovers QRICH1 as a critical mediator that amplifies HBV-induced HMGB1 translocation and secretion through endoplasmic reticulum (ER) stress pathways in hepatocytes. These findings provide novel mechanistic insight into the molecular links between viral infection, ER stress, and the progression of hepatic fibrosis, with implications for targeting QRICH1 in liver disease interventions.

• Bobcat339: Reliable TET Enzyme Inhibition in Epigenetics Res

  2026-04-28

  This article provides a scenario-driven, evidence-based exploration of Bobcat339 (SKU BA4643) as a cytosine structure-based TET enzyme inhibitor for epigenetics research. It addresses real laboratory challenges in DNA methylation regulation, gene transcription modulation, and product selection, supporting scientists with protocol guidance and data transparency.

• Hydrocortisone in Research: Optimizing Glucocorticoid Hormon

  2026-04-27

  Hydrocortisone empowers researchers to dissect glucocorticoid receptor signaling with precision in inflammation and neurodegeneration models. This guide details actionable protocols, advanced troubleshooting, and translates recent reference breakthroughs into practical laboratory strategies.

• Triacetin (Glyceryl Triacetate): Applied Workflows & Trouble

  2026-04-27

  Triacetin’s versatility as a lipid-related biochemical reagent is redefining protocols in apoptosis induction, metabolic modulation, and advanced ocular formulation research. This article delivers stepwise workflow enhancements, actionable troubleshooting, and comparative insights to maximize the scientific impact and reliability of Triacetin from APExBIO.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Technical Workflow G

  2026-04-26

  The Cy3 Goat Anti-Mouse IgG (H+L) Antibody addresses the need for reliable, sensitive detection of mouse IgG in immunofluorescence, flow cytometry, and western blot applications. It is best utilized where specific, quantitative secondary labeling is required for research—not diagnostic—assays. It is not recommended for use in clinical or medical diagnostics or with non-mouse primary antibodies.

• GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor in Redox R

  2026-04-25

  GKT137831 empowers researchers to dissect oxidative stress mechanisms with precision, uniquely modulating Nox1/Nox4-driven ROS in fibrosis, vascular remodeling, and advanced cell signaling assays. Explore protocol optimization, troubleshooting, and cross-study workflows leveraging APExBIO's trusted reagent.

• Formononetin Prevents Oxaliplatin-Induced Neurotoxicity via

  2026-04-24

  This study demonstrates that formononetin activates the Nrf2/HO-1 antioxidant pathway to protect neurons from oxaliplatin-induced peripheral neurotoxicity without compromising its anticancer efficacy. The work addresses a critical gap in chemotherapy-induced peripheral neuropathy research, highlighting a promising strategy for preserving neuronal health during cancer treatment.

• Pazopanib (GW-786034): Applied Workflows for Cancer Research

  2026-04-24

  Pazopanib (GW-786034) empowers cancer researchers with highly selective, multi-targeted receptor tyrosine kinase inhibition, enabling precise angiogenesis and tumor growth studies. This article details actionable protocols, advanced applications, and troubleshooting insights—especially for ATRX-deficient glioma models—making it an indispensable tool in the translational oncology lab.

• SMYD2 Inhibition Mitigates Cisplatin-Induced Renal Fibrosis

  2026-04-23

  This study demonstrates that pharmacological SMYD2 inhibition, using agents such as LLY-507, significantly protects against cisplatin-induced renal fibrosis and inflammation. By elucidating SMYD2's mechanistic role in chronic kidney disease, the findings offer new avenues for epigenetic intervention in fibrosis and highlight translational opportunities for targeted therapies.

• Gastrin I (human): Precision Modulation of Gastric Acid in O

  2026-04-23

  Explore how human Gastrin I peptide advances gastric acid secretion pathway research using organoid models. This article offers a mechanistic deep-dive, protocol parameters, and practical insights distinct from existing literature.

• TAK-715: Precision p38 MAPK Inhibitor for Inflammation Resea

  2026-04-22

  TAK-715 stands out as a potent, selective p38 MAPK inhibitor, enabling high-fidelity dissection of cytokine-driven inflammatory pathways. Its dual-action mechanism and advanced conformational targeting, as validated by recent structural biology, empower researchers to achieve reproducible and translatable results in both cell-based and in vivo models.

• Strategic Use of YC-1 for Translational Hypoxia Research

  2026-04-22

  This article delivers a mechanistically grounded, evidence-forward perspective on YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol as a dual-action tool for translational cancer and hypoxia research. Framing current bottlenecks in hypoxia signaling and tumor microenvironment studies, we dissect how YC-1’s distinct molecular actions—HIF-1α inhibition and sGC activation—address both mechanistic and workflow challenges. By integrating evidence from recent literature and advanced protocols, we provide actionable guidance for translational researchers, while situating APExBIO’s YC-1 as an enabling reagent for next-generation experimental design.

• Abiraterone Acetate: Potent CYP17 Inhibitor for Prostate Can

  2026-04-21

  Abiraterone acetate is a high-potency CYP17 inhibitor and a key tool in castration-resistant prostate cancer (CRPC) research. It acts as a 3β-acetate prodrug with superior solubility and irreversible enzyme inhibition. APExBIO provides validated, high-purity Abiraterone acetate (A8202) for robust mechanistic and translational studies.

• 7ACC2: Monocarboxylate Transporter 1 Inhibitor for Cancer Me

  2026-04-21

  7ACC2 is a dual-action monocarboxylate transporter 1 inhibitor that uniquely blocks both lactate and mitochondrial pyruvate transport, enabling high-precision dissection of cancer metabolism and immunometabolic crosstalk. Optimized for robust antitumor and radiosensitizing effects, 7ACC2 empowers advanced experimental workflows targeting metabolic vulnerabilities in tumor models.

14461 records 1/965 page Next 12345 下5页 Last page